Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 2058-2066, October 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garner, R. C.
Right arrow Articles by Miller, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garner, R. C.
Right arrow Articles by Miller, J. A.

Liver Microsomal Metabolism of Aflatoxin B1 to a Reactive Derivative Toxic to Salmonella typhimurium TA 15301

R. Colin Garner2, Elizabeth C. Miller and James A. Miller3

McArdle Laboratory for Cancer Research, University of Wisconsin Medical Center, Madison, Wisconsin 53706

A reduction in the survival of Salmonella tryphimurium TA 1530 was observed when the bacteria were incubated with aflatoxin B1, rat liver microsomes, and a reduced nicotinamide adenine dinucleotide phosphate-generating system. The lethality appeared to depend on the formation of a metabolite of aflatoxin B1 by a mixed-function oxygenase system. The killing was very rapid; only 1% of the bacteria were able to form colonies after 2 min of incubation with large amounts of microsomes and aflatoxin B1. Attempts to separate the toxic metabolite from the microsomal system have not been successful.

Toxic metabolites for S. typhimurium TA 1530 were also formed if aflatoxin B1 was replaced by either aflatoxin G1 or sterigmatocystin in the microsome-mediated toxicity assay. Except for aflatoxicol, the derivatives that were tested either had much less activity or were inactive.

The livers from a number of other species of rodents and a single autopsy sample of human liver also were active in the microsome-mediated aflatoxin B1 toxicity assay. The addition of RNA or DNA to the incubation mixture inhibited the killing of the bacteria.

The RNA (which was reisolated after its incubation with aflatoxin B1), liver microsomes, and a reduced nicotinamide adenine dinucleotide phosphate-generating system showed a low, broad absorption, with a maximum at 366 to 370 nm. This high wavelength absorption was not removed by Sephadex G-10 chromatography of the RNA or by extraction procedures and appeared to be attributable to covalently bound aflatoxin B1 toxicity assay. The formation of the conjugated RNA was dependent on reduced nicotinamide adenine dinucleotide phosphate and was inhibited by the addition of aniline; the amount formed was a function of the activity of the mixed-function oxygenases in the incubation mixture.

On the basis of the data presented, it is tentatively suggested that the derivative that is toxic to S. typhimurium TA 1530 and the one that reacts with nucleic acids are identical. The possible relationship of this derivative to the hepatocarcinogenicity of aflatoxin B1 is discussed.

1 This work was supported by Grant CA-07175 of the National Cancer Institute, USPHS.

2 Recipient of a Damon Runyon Postdoctoral Fellowship, 1970 to 1972. Present address: Department of Experimental Pathology and Cancer Research, University of Leeds, 171 Woodhouse Lane, Leeds LS2 3AR, Yorkshire, England.

3 To whom reprint requests should be addressed.

Received 4/ 3/72. Accepted 6/ 9/72.




This article has been cited by other articles:


Home page
Cancer Res.Home page
K. A. McGlynn, K. Hunter, T. LeVoyer, J. Roush, P. Wise, R. A. Michielli, F.-M. Shen, A. A. Evans, W. T. London, and K. H. Buetow
Susceptibility to Aflatoxin B1-related Primary Hepatocellular Carcinoma in Mice and Humans
Cancer Res., August 1, 2003; 63(15): 4594 - 4601.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. Goldman and P. G. Shields
Food Mutagens
J. Nutr., March 1, 2003; 133(3): 965S - 973.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
B. Ames
Identifying environmental chemicals causing mutations and cancer
Science, May 11, 1979; 204(4393): 587 - 593.
[Abstract] [PDF]


Home page
ScienceHome page
Z. Wong and D. Hsieh
Aflatoxicol: major aflatoxin B1 metabolite in rat plasma
Science, April 21, 1978; 200(4339): 325 - 327.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.